| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 12.5 | 30.7 | 2.4 |
| Total income | 12.5 | 30.7 | 2.4 |
| Profit before exceptional items & tax | 1.7 | 2.3 | 0.1 |
| Profit before tax | 1.7 | 2.3 | 0.1 |
| Net profit | 1.3 | 1.6 | 0.1 |
| Operating margin | 13.6% | 7.5% | 4.2% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +1200.00% |
|---|---|
| Net profit, quarter on quarter | -18.80% |
| Revenue, year on year | +420.80% |
BSE results filing, BSE: 524238. Figures extracted from the filing.
Gujarat Inject (Kerala) Ltd: key numbers
- Share price
- ₹9.45
- Market cap
- ₹138.4 Cr
- Revenue (annual)
- ₹36.32 Cr
- Net profit (annual)
- ₹1.81 Cr
- P/E (TTM)
- 46.3×Sector 50.4×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gujarat Inject (Kerala) Ltd
All →Gujarat Inject (Kerala) Stock Split
Gujarat Inject Kerala Ltd announced the completion of its 1:10 stock split. Shareholders holding physical certificates must now submit documentation to the RTA to receive dematerialized shares.
Gujarat Inject (Kerala) Management Change
Gujarat Inject Kerala Ltd has appointed M/s. S N D K & Associates LLP as the company's new Statutory Auditor. The appointment is effective from September 29, 2026.
Gujarat Inject (Kerala) Other Announcement
Gujarat Inject (Kerala) Limited has appointed M/s. S N D K & Associates LLP as the company's statutory auditor, effective from the conclusion of its ensuing AGM.
Gujarat Inject (Kerala) Annual General Meeting
Gujarat Inject (Kerala) Limited scheduled its 35th Annual General Meeting for September 29, 2026. The meeting will address financial statements, director appointments, and auditor approval.
Gujarat Inject (Kerala) Q4 FY26 Results: Net Profit ₹1.6 Cr, Up 1500.0% YoY
Gujarat Inject (Kerala) Ltd reported revenue from operations of ₹30.7 Cr (+631.0% YoY) and net profit of ₹1.6 Cr (+1500.0% YoY) for Q4 FY26.
- Key figure
- Net profit ₹1.6 Cr · +1500.0% YoY